
KYPROLIS®+Darzalex® (daratumumab) and dexamethasone (DKd) Regimen
Learn more about how a DKd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the CANDOR study (DKd vs Kd).
Learn more about how a DKd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the CANDOR study (DKd vs Kd).
Learn more about how a KRd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the ASPIRE study (KRd vs Rd).
Learn more about how a Kd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the ENDEAVOR study (Kd vs Vd).
Get important data from the CANDOR study (DKd vs Kd) and a DKd regimen for appropriate adult patients with relapsed multiple myeloma.
Review a hypothetical case study of a patient with multiple myeloma at first relapse and learn about her DKd treatment plan.
Learn about the appropriate dosing for each regimen containing KYPROLIS®.
See the CANDOR study (DKd vs Kd) data and learn how appropriate adult patients with relapsed multiple myeloma may benefit from a DKd regimen.
Learn more about the CANDOR study (DKd vs Kd) and how DKd may help your adult patients with relapsed multiple myeloma.
Please see full Prescribing Information.
See the CANDOR study (DKd vs Kd) data and learn how appropriate adult patients with relapsed multiple myeloma may benefit from a DKd regimen.
Learn more about the CANDOR study (DKd vs Kd) and how DKd may help your adult patients with relapsed multiple myeloma.